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in England.monitoring systems due to variation in local application and data collection
methods. The results of this work and the PUWA led to the development of recom-
mendations for PU monitoring practice, many of which are internationally relevant.
ª 2015 The Authors. Published by Elsevier Ltd. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
As part of a national safety agenda a number of
initiatives have been introduced throughout the
NHS in England to reduce avoidable pressure ulcer
(PU) harm including prevalence reporting through
the Safety Thermometer (STh) [1] and incident
reporting through Incident Reporting Systems (IRS)
[2], and the Strategic Executive Information Sys-
tem (STEIS) for the reporting of Serious Incidents
[3]. Full details of the adverse event reporting
monitoring systems are detailed elsewhere [13].
While these initiatives have been implemented
across England, a lack of comprehensive guidance
has led to concerns about variation in local
implementation (e.g. type of ulcer to be reported,
classification system to be used) and a subsequent
lack of consistency for pressure ulcer reporting
across the country [4].
A wider literature has also identified difficulties
in the interpretation of adverse event data
collected by designated teams [5e11], yet there is
a prevailing culture of adverse event monitoring in
the NHS in England. This raises concerns regarding
inappropriate interpretation and comparisons of
data between NHS organisations [4] and by
healthcare Commissioners in their assessment of
Trust1 performance, with (in some cases) associ-
ated financial penalties [12]. The Tissue Viability
Society (TVS) therefore funded a two-part project,
supported by NHS England, to inform interpreta-
tion and further development of PU adverse event
monitoring. The work comprised 1) a ‘gold stan-
dard’ Pressure Ulcer/Wound Audit (PUWA) [13]
reported pp. 3e15 and 2) a survey of monitoring
systems in participating hospitals.
In part 1 a PUWA [13] was conducted using ‘gold
standard’ PU prevalence methods in a stratified
random sample of NHS Trusts providing in-patient
services for adult patient populations in England
(reported pp. 3e15). Wards from a range of spe-
cialities were randomly selected from partici-
pating Trusts and included in the study which was
conducted on the STh census date in Octobere managed by NHS Trusts2014. A total of 2239 patients were fully assessed
as part of the PUWA from a total bed-base of 2468
beds across 121 wards randomly selected from 24
of 34 (70.6%) Trusts who agreed to participate.
The results indicate high levels of under-reporting
for all PU categories across existing monitoring
systems. The high level of under-reporting of
category 3 and 4 ulcers raises particular concerns
because such ulcers are a serious patient harm
[13].
While planning the part 1 PUWA the need to
elicit further information and explore differences
between Trusts in their recording and reporting of
PUs in NHS adverse event monitoring systems was
highlighted. This prompted part 2 of the project; a
survey of the NHS hospitals in England who
participated in part 1 and is the focus of this paper.2. Aim
The aim of the survey was to explore differences
between NHS Trusts in the implementation of PU
adverse event monitoring systems (STh, IRS, STEIS)
and the recording of PUs in nursing
documentation.3. Methods
Twenty-four UK NHS hospital Trusts who took part
in part 1 PUWA [13] were invited to participate in a
survey. The survey questionnaire comprised 41
items incorporating single and multiple response
option items and free-text items about local
practice for the recording and reporting of PUs in
NHS monitoring systems (STh, IRS, STEIS)
incorporating:
1. Routine reporting practice in nursing docu-
mentation i.e. classification systems used, and
differentiation of different types of skin ulcers.
2. Local reporting practice for each monitoring
systems for:
a) Inclusion of device ulcers.
b) Inclusion of unstageable ulcers.
c) Inclusion of DTI.
Fig. 1 Pressure ulcer classification systems used in
nursing documentation.
18 S. Coleman et al.3. Specific system processes for IRS (aeg), STEIS
(e, f and h) and STh (i) with regard to the:
a) Inclusion of category  1 or  2 ulcers.
b) Inclusion of combined pressure/IAD ulcers.
c) Inclusion of inherited ulcers i.e. Present on
Admission (POA).
d) Inclusion of acquired ulcers i.e. Hospital
Acquired (HA).
e) Inclusion of avoidable.
f) Inclusion of unavoidable ulcers.
g) Definition for inherited ulcers.
h) Deterioration.
i) Data collection methods.
4. Validation processes for each monitoring
system.
5. Data reporting to Trust Boards and Healthcare
Commissioners including the data sources used
and the type, categories, origin (i.e. POA or
HA) and attribution (i.e. avoidable or un-
avoidable) of ulcers reported and PU targets.
The survey questionnaire was reviewed by the
authors and an external PU professional group to
ensure face and content validity. It was also pilo-
ted prior to implementation to ensure it was easy
to understand and use. No formal ethical scrutiny
was required or sought for this survey. Question-
naires were completed electronically or by hand
by the PUWA Trust lead in liaison with appropriate
key people in the organisation [13]. Completed
questionnaires were entered onto a secure,
bespoke spreadsheet and analysis was undertaken
using simple descriptive statistics.4. Results
All 24 (100%) NHS Trusts included in the part 1
PUWA [13] participated in the survey and there
were high levels of data completeness (99.1%). The
questionnaire results are presented as routine
practice in nursing documentation, local reporting
practice for adverse event monitoring systems,
specific system processes, validation processes for
monitoring systems, reporting to Trust Boards and
NHS Commissioners and PU targets.
4.1. Nursing documentation
All Trusts reported that they use the NPUAP/EPUAP
(2009) classification system or an adaptation of it
within their nursing documentation (Fig. 1). Only 5
(20.8%) Trusts use the full classification (categories
1e4 and Unstageable and Deep Tissue Injury), 4
(16.7%) use categories 1e4 and Unstageable, 11(45.8%) use categories 1 to 4 only, and 4 (16.7%)
use the NHS Midlands and East Classification which
is an adaptation of the NPUAP/EPUAP(2009) clas-
sification where unstageable ulcers are recorded
as category 3.
A majority of participating Trusts (20/24 83.3%)
indicated that they recognised the difference be-
tween PUs and Incontinence Associated Dermatitis
(IAD) in their nursing documentation. IAD was
documented as a Moisture lesion by (20/24, 83.3%)
participating Trusts with only 4/24 (16.7%) using
both Moisture lesion and IAD terminology. A large
proportion of Trusts (17/24, 70.8%) indicated that
they do not distinguish between PUs and device
related ulcers in their nursing documentation.
4.2. Local reporting practices
Of the 24 Trusts, the majority indicated that they
include reports of device ulcers within their PU
adverse event monitoring systems including 75.0%
for STh, 87.5% for IRS and 75.0% for STEIS. There is
variation in the way in which participating Trusts
indicated they reported unstageable and DTI PUs
across reporting systems (Fig. 2), with differences
noted between classification for clinical records
and actual reporting on the monitoring systems. An
important minority of Trusts (8.3e25.0%) do not
report Unstageable PUs with slightly higher levels
of non-reporting for DTI (25e37.5%) (Fig. 2).
However, additional comments by Trusts suggested
the PU would be reported once the category of
ulcer (1e4) could be established with a period of
‘watchful waiting’.
4.3. Specific monitoring system processes
4.3.1. IRS
There were 16 (66.7%) Trusts who confirmed that
they report combined PU/IADs and 11 (45.8%) who
report IAD to the IRS. Trusts were asked to confirm
Fig. 2 Category reported for unstageable and DTI PUs across different adverse event monitoring systems.
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ing. Fifty per cent of Trusts confirmed that they
report category 1 and above ulcers, and 50% report
category 2 and above ulcers to IRS.
Most Trusts indicated that they routinely re-
ported whether PUs were POA (23/24, 95.8%) or HA
(22/24, 91.7%) on the IRS. It should be noted that
there was variation in the way that POA was
defined with 10/24 (41.7%) Trusts indicating this
would be reported if a PU was recorded during the
‘on admission’ skin assessment and 12/24 (50.0%)
Trusts indicating they use the STh definition of an
‘Old’ PU, that is, if recorded at any time within
72 h of admission (Fig. 3). There were 10 (41.7%)Fig. 3 Definition of present on admission (POA).Trusts who also report whether the PUs were
avoidable or unavoidable on the IRS.
4.3.2. STEIS
The majority (19/24, 79.2%) of Trusts indicated
that they do not assess whether ulcers are avoid-
able before reporting to STEIS, and 15 (62.5%)
Trusts do not remove PUs from STEIS if they are
subsequently found to be unavoidable. Addition-
ally, if a STEIS reported PU deteriorates, just over
half (13/24, 54.2%) of the Trusts confirmed that
they would submit a further report to document
this.
4.3.3. Safety thermometer
Table 1 details the initial data collection methods
used for STh and the use of patient identifiers (e.g.
NHS number, hospital number, date of birth) var-
ies, with 10/24 (41.7%) confirming that they do use
patient identifiers for their initial data collection,
and 13/24 (54.2%) confirming that they do not.
4.4. Validation processes for each moni-
toring system
The majority of Trusts had validation processes in
place for the STh submission (17/24, 70.8%) and
IRS (22/24, 91.7%). The categories of ulcer vali-
dated for IRS varied, though all Trusts (with a
Table 1 Initial data collection methods for safety
thermometer.
N ¼ 24
On paper with no patient
identifiers (e.g. NHS
number, hospital number,
date of birth)
5 (20.8%)
On paper with patient
identifiers
5 (20.8%)
Electronically with patient
identifiers
3 (12.5%)
Combination of paper and
electronic with no patient
identifiers
8 (33.3%)
Combination of paper and
electronic with patient
identifiers
2 (8.3%)
Missing 1 (4.2%)
20 S. Coleman et al.validation process) confirmed that it was in place
for all category 3 and category 4 PUs (Table 2).
Questions around the validation of data reported
to STEIS were not applicable because the report
requires investigation of the ulcer as a serious
incident.
Participating Trusts indicated that the Tissue
Viability Nurse was the most likely person to un-
dertake ulcer validation for the IRS (21/22, 95.5%),
with a number of Trusts indicating a range of staffTable 2 Validation processes including the category
of ulcers validated and methods.
STh
(N ¼ 17)
IRS
(N ¼ 22)
Category of PUs validated
Category 1 N/A 7 (31.8%)
Category 2 N/A 20 (90.9%)
Category 3 N/A 22 (100.0%)
Category 4 N/A 22 (100.0%)
Unstageable N/A 19 (86.4%)
DTI N/A 14 (63.6%)
Validation methods
Direct assessment of the
patient
10 (58.8%) 21 (95.5%)
Liaison with the
ward/discussion about
the patient
13 (76.5%) 15 (68.2%)
From patient clinical
records
5 (29.4%) 13 (59.1%)
Checked against incident
reporting system
8 (47.1%) N/A
Checked against additional
internal register
2 (11.8%) 0 (0.0%)
Other 1 (5.9%) 3 (13.6%)were involved including Ward Sisters/Managers (6/
22, 27.3%), Matrons (8/22, 36.4%) and other staff
(2/22, 9.1%) including a PU Panel (including the
Director of Nursing) and a Community Nursing Sis-
ter. For STh Tissue Viability Nurses were also most
likely to undertake the validation process (11/17,
64.7%) with Ward Sister/Managers (5/17, 29.4%),
Matrons (4/17, 23.5%) and other staff (6/17, 35.3%)
also being involved (including Quality Assurance
Nurses, Audit Leads, Specialist Nurse practitioners
from other fields (i.e. falls), Senior Staff Nurse and
Deputy Chief Nurse).
Validation methods varied across Trusts and
monitoring systems and included; direct assess-
ment of the patient, liaison with the ward/dis-
cussion about the patient, from patient clinical
record, checking against IRS and/or additional in-
ternal registers (Table 2). It is noteworthy that the
validation process for the IRS (21/22, 95.5%) was
more likely to involve direct assessment of the
patient than the STh (10/17, 58.8%), as well as the
use of other data sources. For STh the validation
process would more likely involve liaison with the
ward/discussion about the patient (13/17 76.5%)
(Table 2).
4.5. Reporting to trust boards and health-
care commissioners and targets
Local reporting requirements to respective Trust
Boards and health service commissioners were
explored. Respondents indicated that multiple
data sources are reported to Trust Boards including
STh data (24/24, 100.0%), IRS (21/24, 87.5%), and
STEIS (24/24 100.0%), with a similar proportion of
Trusts reporting this data to the local health ser-
vice Commissioners (Table 3). The majority of
Trusts included both PUs and device ulcers, though
3 Trusts do not report device ulcers to the Trust
Boards and Commissioners (Table 3). The results
indicate that while some Trusts reported incidents
of all ulcer categories to their Trust Board and
Commissioners only Category 4 PUs were reported
by all responding Trusts to both their Trust Board
and Commissioners. There was variation in the
reporting of unstageable and DTI ulcers with the
largest proportion (29.2%) indicating they would be
reported as category 3 ulcers. DTI ulcers were less
likely to be reported to Trust boards/commis-
sioners compared to unstageable ulcers (Fig. 4).
When considering the origin and attribution of
PUs, responses from participating Trusts indicated
variation in the type of reporting undertaken. The
largest proportion indicated that all four PU types
‘POA, HA, Avoidable, Unavoidable’ would be
Table 3 Reporting of PUs to trusts boards and commissioners.
Trust board N ¼ 24 Commissioners N ¼ 24
Data sources reported
STh 24 (100.0%) 21 (87.5%)
IRS 21 (87.5%) 23 (95.8%)
Other 1 (4.2%) N/A
Missing 0 (0.0%) 1 (4.2%)
STEIS reported PUs
Yes 24 (100.0%) 23 (95.8%)
No 0 (0.0%) 1 (4.2%)
Type of ulcers included in reported incidents
PUs 24 (100.0%) 23 (95.8%)
Device ulcers 21 (87.5%) 20 (83.3%)
Missing 0 (0.0%) 1 (4.2%)
Categories included
Category 1 10 (41.7%) 11 (45.8%)
Category 2 21 (87.5%) 17 (70.8%)
Category 3 23 (95.8%) 23 (95.8%)
Category 4 24 (100.00%) 23 (95.8%)
Unstageable 12 (50.0%) 10 (41.7%)
DTI 6 (25.0%) 7 (29.2%)
Missing 0 (0.0%) 1 (4.2%)
PU origin and attribution in reported incidents
POA, HA, avoidable,
unavoidable
8 (33.3%) 9 (37.5%)
POA only 0 (0.0%) 1 (4.2%)
POA, HA 2 (8.3%) 4 (16.7%)
POA, HA, avoidable 1 (4.2%) 2 (8.3%)
HA only, 3 (12.5%) 2 (8.3%)
HA, Avoidable 3 (12.5%) 1 (4.2%)
HA, avoidable, unavoidable 7 (29.2%) 3 (12.5%)
Avoidable only 0 (0.0%) 1 (4.2%)
Missing 0 (0.0%) 1 (0.0%)
PU data reported
Number of patients with PUs 10 (41.7%) 10 (41.7%)
Number of patients with PUs,
number of pressure/device
ulcers
1 (4.2%) 0 (0.0%)
Number of patients with PUs,
number of PUs, % of
patients with PUs/number
of admissions
0 (0.0%) 1 (4.2%)
Number of patients with PUs,
number of PUs, number of
PUs/1000 bed days
1 (4.2%) 2 (8.3%)
Number of patients with PUs,
% of patients with PUs/
number of admissions
1 (4.2%) 1 (4.2%)
Number of patients with PUs,
% of patients with PUs/
number of admissions,
number of PUs/1000 bed
days
1 (4.2%) 0 (0.0%)
Number of patients with PUs,
number of PUs/1000 bed
days
2 (8.3%) 1 (4.2%)
(continued on next page)
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Table 3 (continued )
Trust board N ¼ 24 Commissioners N ¼ 24
Number of patients with PUs
and othera
1 (4.2%) 1 (4.2%)
Number of PUs 4 (16.7%) 1 (4.2%)
Number of PUs, % of patients
with PUs/number of
admissions
1 (4.2%) 1 (4.2%)
Number of PUs, number of
PUs/1000 bed days
2 (8.3%) 2 (8.3%)
Number of PUs, othera 0 (0.0%) 1 (4.2%)
Othera 0 (0.0%) 2 (8.3%)
Missing 0 (0.0%) 1 (4.2%)
a Other: local reporting of varied PU data.
22 S. Coleman et al.included in their reporting to the Trust Board (8/
24, 33.3%) and Commissioners (9/24, 37.5%). Re-
spondents reported 13 different combinations of
ways in which PU information was reported to
Trust Boards and Commissioners, although the
largest proportion of Trusts (10/24, 41.7%) indi-
cated they reported ‘number of patients with PUs’
only (Table 3).
A large proportion (19/24, 79.2%) of partici-
pating Trusts indicated they had Commissioning
targets for PUs. The targets were developed
locally and the 18 descriptions provided could not
be categorised but 3 examples include; elimination
of avoidable grade 2,3 and 4 PUs, reduction of old
and new PUs by 40% from a 5% baseline, 10%
reduction in the number of patients with avoidableFig. 4 Category reported for unstageable andPUs. The detail of these targets and associated
financial penalties/incentives for 18 Trusts indi-
cate great variation in Commissioning practices.5. Discussion
The results of the survey add to the wider inter-
national debate relating to the interpretation of
adverse event data and changes over time to
assess improvement in patient safety and re-
ductions in patient harms [5e11]. In this study we
have described the local implementation of a na-
tional policy framework for one adverse event,
PUs. We have identified considerable variation in
the local implementation of national policy, in theDTI PUs to trust boards and commissioners.
Pressure ulcer and wounds reporting 23absence of clearly defined parameters for the
reporting of PUs. Lack of standardisation is also an
international concern with recent guidance incor-
porating PU outcome indicators and emphasising
the need for consistency in PU prevalence and
incidence studies [14].
Our findings demonstrate that the international
PU classification system [14] incorporating cate-
gories 1e4, unstageable and DTI ulcers have not
been fully adopted in England. Further work should
be undertaken internationally to establish whether
adoption difficulties are encountered elsewhere
and how these can be addressed. We found that at
a basic level there is variation in the definition of
inherited (i.e. POA) PUs and the classification
system used, particularly in relation to the inclu-
sion of unstageable and DTI ulcers. These cate-
gories are therefore inconsistently reported across
all PU reporting and adverse event monitoring
systems and to Trust Boards and Commissioners.
There is also inconsistent reporting of category 1
PUs in IRS and to Trust Boards and Commissioners.
Whilst it can be argued that the impact of the in-
clusion or not of device ulcers, combined pres-
sure/IAD, unstageable ulcers and DTI in both STh
and IRS is small, due to the small proportion of
these ulcers overall [13], concerns about these
issues have previously dominated arguments about
Trust to Trust comparisons [4] and missed the real
issue identified by the PUWA, which is high levels
of under-reporting [13].
In the previous consensus work undertaken by
the Tissue Viability Society [4] there was consensus
on the inclusion or not of combined pressure/IAD,
unstageable, DTI, avoidable and unavoidable ul-
cers and that the STh 72 h definition of ‘Old’ should
be discarded. The inclusion of category 1 or
inherited/acquired PUs was not discussed as these
were already defined as part of the STh reporting
process, i.e. the STh data reporting includes both
inherited and acquired ulcers (the issue was the
72 h definition) and require only category 2 and
above ulcers [13].
Results indicate that in a representative group
of randomly selected Trusts, despite previous
recommendations, there remains local interpre-
tation and inclusion/definition of 3 data compo-
nents reported to STh (items 1e3 below) and 9
components in data reported from IRS to NLRS,
Trust Boards and Commissioners as follows:
1) Inclusion of device ulcers (yes or no).
2) Inclusion of unstageable ulcers (yes or no).
3) Inclusion of DTI (yes or no).
4) Inclusion of combined pressure/IAD ulcers (yes
or no).5) Inclusion of category  1 ulcers or category  2
ulcers.
6) Inclusion of inherited ulcers (yes or no).
7) Inclusion of acquired ulcers (yes or no).
8) Inclusion of avoidable and unavoidable ulcers
(yes or no).
9) POA definition or STh 72 h definition of ‘Old’ for
inherited ulcers.
These fundamental differences in reporting
preclude Trust to Trust comparisons, even for
STh, as despite its written methodology there is
variation in its local application and data collec-
tion methods. The interpretation of data from the
NHS PU adverse event monitoring systems in En-
gland is further complicated by the use of clinical
staff to capture adverse event data within the
monitoring systems and the completeness of
clinical records with high levels of under-
reporting [13].
While in the present study we have focussed on
PU adverse event monitoring systems in England,
the principles of the 9 components have interna-
tional relevance for ensuring a consistent
approach. Variation in their adoption needs care-
ful consideration prior to making comparisons be-
tween different healthcare organisations,
hospitals or countries.6. Conclusion
In this survey we have described the local imple-
mentation of a national policy framework for one
adverse event, PUs by comparing current data
sources including in-patient STh prevalence data
and incident reporting to the IRS and STEIS. The
key findings indicate substantial variation in the
local implementation of national policy, demon-
strated by different definitions and variation in
data collection and validation processes. These
differences preclude Trust-to-Trust comparisons of
PU prevalence and incident rates. The results add
to the wider international debate relating to the
interpretation of adverse event data and its use in
patient safety improvement initiatives.
The collective findings of the part 1 PUWA work
[13] and the part 2 survey indicate that current
systems used on a local, regional and national level
to monitor PU patient harm lack standardisation,
are characterised by high levels of under-reporting
and despite their limitations have been used to
compare Trusts and in some cases lead to financial
penalties. Consideration of this work led to the
development of 5 key recommendations to
improve future PU monitoring, many of which are
24 S. Coleman et al.internationally relevant as detailed below (NB:
specific points relevant to England only are deno-
ted with2):7. Recommendation 1
7.1. National policy makers, commissioners
and others reviewing PU monitoring should
a) Understand the limitations of the data sources.
b) Implement a checklist to confirm use of the 9
key numerator PU monitoring components (see
recommendation 2).
c) Consider the impact of deviations from the
standard 9 key numerator components upon PU
rates (see recommendation 2).
d) Assess the level of under-reporting to support
informed data interpretation.
e) Take into account the original purpose of the
PU monitoring system (for example, to under-
stand the scale of problem or to provide a
benchmark for local improvement).
f) Avoid comparisons between Trusts (or hospitals
and other healthcare organisations).
g) Rationalise the burden of multiple data
collection approaches taking into account local
utility of PU reporting.
h) Incentivise improvements in data capture
methods.2
i) cross reference IRS and STEIS data.28. Recommendation 2
8.1. Standardise 9 key numerator compo-
nents of PU monitoring systems
1) Inclusion of device ulcers (yes).
2) Inclusion of combined pressure/IAD ulcers
(yes).
3) Inclusion of unstageable ulcers (yes).
4) Inclusion of DTI (no, until category can be
established).
5) Inclusion of category  2 ulcers (not
category  1).
6) Inclusion of inherited ulcers (yes).
7) Inclusion of acquired ulcers (yes).
8) Inclusion of avoidable and unavoidable ulcers
(yes).
9) Use of the POA definition for inherited ulcers
(yes), i.e. discard the STh 72 h. definition of
‘Old’29. Recommendation 3
9.1. National policy makers should
a) Consider streamlining the current requirement
of 3 data reporting systems (STh, NLRS and
STEIS).2
b) Clarify to commissioners the terms prevalence,
incidence and incident monitoring and if
applicable (i.e. prevalence and incidence only)
define the denominator.2
c) Undertake further work with the clinical com-
munity and data experts to consider how ulcers
which have deteriorated are captured in inci-
dent reports.
d) Clarify the requirements for removal from
STEIS of severe PUs later assessed as
unavoidable.210. Recommendation 4
10.1. Trusts should
a) Establish local systems which improve the ac-
curacy of PU reporting.2
b) Make incident reports clearly accessible in the
clinical record.2
c) Improve handover systems at ward level which
ensure all harms are known to the nurse in
charge.2
d) Improve the process of escalating category 3
and 4 PUs reported as incidents on the local IRS
to STEIS.211. Recommendation 5
11.1. Clinical, performance, improvement,
commissioning and academic professionals
should
Work together to explore methods to improve data
capture and accurate reporting; the benefits of
monitoring patient harm and; the use of data to
incentivise reductions in harm.Conflict of interest statement
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